Michael Vander Hoek - 29 Aug 2022 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role: Chief Financial Officer
Signature: /s/ Michael Vander Hoek
Issuer symbol: SHPH
Transactions as of: 29 Aug 2022
Net transactions value: $0
Form type: 3
Filing time: 07 Sep 2022, 09:20:06 UTC
Next filing: 30 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SHPH	COMMON STOCK						6,095	29 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The undersigned became a Reporting Person subject to Section 16 reporting on August 29, 2022 at the time Shuttle Pharmaceuticals Holdings, Inc ("Company") completed its initial public offering ("IPO"). At the time of the IPO, the Reporting Person was the beneficial owner of 6,095 shares of common stock of the Company, consisting of 6,095 restricted stock units ("RSUs"), or which 4,063 RSUs have fully vested and 2,032 RSUs which remain subject to vesting.

Content

The undersigned became a Reporting Person subject to Section 16 reporting on August 29, 2022 at the time Shuttle Pharmaceuticals Holdings, Inc ("Company") completed its initial public offering ("IPO"). At the time of the IPO, the Reporting Person was the beneficial owner of 6,095 shares of common stock of the Company, consisting of 6,095 restricted stock units ("RSUs"), or which 4,063 RSUs have fully vested and 2,032 RSUs which remain subject to vesting.